CASTLE BIOSCIENCES, INC. Diluted Shares Outstanding (Weighted Average)
CASTLE BIOSCIENCES, INC. (CSTL) reported Diluted Shares Outstanding (Weighted Average) of 30.40 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 30.40M shares, a 2.89% increase year-over-year.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 29.89M shares, a 4.47% increase year-over-year.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 29.34M shares, a 3.82% decline year-over-year.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 29.07M shares, a 1.12% decline year-over-year.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 28.99M shares, a 0.92% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 29.25M shares, a 9.15% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 26.80M shares, a 2.87% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 26.05M shares, a 3.65% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 30.40M shares 10-Q · filed 2026-07-30 | 30.15M shares 10-Q · filed 2026-07-30 | 29.88M shares derived: average of 3 quarters · filed 2026-07-30 | 29.68M shares derived: average of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | 29.89M shares 10-Q · filed 2026-05-06 | 29.61M shares derived: average of 2 quarters · filed 2026-05-06 | 29.43M shares derived: average of 3 quarters · filed 2026-05-06 | 29.46M shares derived: average of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | 29.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 29.21M shares derived: average of 2 quarters · filed 2026-02-26 | 29.32M shares derived: average of 3 quarters · filed 2026-07-30 | 28.99M shares 10-K · filed 2026-02-26 | ||
| 2025-09-30 | 29.07M shares 10-Q · filed 2025-11-03 | 29.31M shares derived: average of 2 quarters · filed 2026-07-30 | 28.87M shares 10-Q · filed 2025-11-03 | 29.43M shares derived: average of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | 29.55M shares 10-Q · filed 2026-07-30 | 28.76M shares 10-Q · filed 2026-07-30 | 29.55M shares derived: average of 3 quarters · filed 2026-07-30 | 29.52M shares derived: average of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | 28.61M shares 10-Q · filed 2026-05-06 | 29.56M shares derived: average of 2 quarters · filed 2026-05-06 | 29.51M shares derived: average of 3 quarters · filed 2026-05-06 | 29.31M shares derived: average of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | 30.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 29.95M shares derived: average of 2 quarters · filed 2026-02-26 | 29.55M shares derived: average of 3 quarters · filed 2026-02-26 | 29.25M shares 10-K · filed 2026-02-26 | ||
| 2024-09-30 | 29.40M shares 10-Q · filed 2025-11-03 | 29.07M shares derived: average of 2 quarters · filed 2025-11-03 | 28.84M shares 10-Q · filed 2025-11-03 | 28.16M shares derived: average of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | 28.74M shares 10-Q · filed 2025-08-04 | 28.54M shares 10-Q · filed 2025-08-04 | 27.75M shares derived: average of 3 quarters · filed 2026-02-26 | 27.52M shares derived: average of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | 27.48M shares 10-Q · filed 2025-05-05 | 27.26M shares derived: average of 2 quarters · filed 2026-02-26 | 27.12M shares derived: average of 3 quarters · filed 2026-02-26 | 27.02M shares derived: average of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | 27.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 26.93M shares derived: average of 2 quarters · filed 2026-02-26 | 26.87M shares derived: average of 3 quarters · filed 2026-02-26 | 26.80M shares 10-K · filed 2026-02-26 | ||
| 2023-09-30 | 26.83M shares 10-Q · filed 2024-11-04 | 26.78M shares derived: average of 2 quarters · filed 2024-11-04 | 26.73M shares 10-Q · filed 2024-11-04 | 26.64M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | 26.73M shares 10-Q · filed 2024-08-05 | 26.67M shares 10-Q · filed 2024-08-05 | 26.58M shares derived: average of 3 quarters · filed 2025-02-27 | 26.51M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | 26.61M shares 10-Q · filed 2024-05-02 | 26.50M shares derived: average of 2 quarters · filed 2025-02-27 | 26.44M shares derived: average of 3 quarters · filed 2025-02-27 | 26.35M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | 26.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 26.36M shares derived: average of 2 quarters · filed 2025-02-27 | 26.26M shares derived: average of 3 quarters · filed 2025-02-27 | 26.05M shares 10-K · filed 2025-02-27 | ||
| 2022-09-30 | 26.32M shares 10-Q · filed 2023-11-02 | 26.19M shares derived: average of 2 quarters · filed 2023-11-02 | 25.94M shares 10-Q · filed 2023-11-02 | 25.78M shares derived: average of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | 26.06M shares 10-Q · filed 2023-08-02 | 25.75M shares 10-Q · filed 2023-08-02 | 25.61M shares derived: average of 3 quarters · filed 2023-08-02 | 25.53M shares derived: average of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | 25.42M shares 10-Q · filed 2023-05-03 | 25.38M shares derived: average of 2 quarters · filed 2023-05-03 | 25.35M shares derived: average of 3 quarters · filed 2023-05-03 | 25.28M shares derived: average of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | 25.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 25.31M shares derived: average of 2 quarters · filed 2023-02-28 | 25.24M shares derived: average of 3 quarters · filed 2023-02-28 | 25.14M shares 10-K · filed 2023-02-28 | ||
| 2021-09-30 | 25.29M shares 10-Q · filed 2022-11-02 | 25.19M shares derived: average of 2 quarters · filed 2022-11-02 | 25.07M shares 10-Q · filed 2022-11-02 | 24.03M shares derived: average of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | 25.09M shares 10-Q · filed 2022-08-08 | 25.00M shares 10-Q · filed 2022-08-08 | 23.62M shares derived: average of 3 quarters · filed 2022-08-08 | 22.70M shares derived: average of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | 24.91M shares 10-Q · filed 2022-05-09 | 22.88M shares derived: average of 2 quarters · filed 2022-05-09 | 21.90M shares derived: average of 3 quarters · filed 2022-05-09 | 20.81M shares derived: average of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | 20.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 20.39M shares derived: average of 2 quarters · filed 2022-02-28 | 19.44M shares derived: average of 3 quarters · filed 2022-02-28 | 18.93M shares 10-K · filed 2022-02-28 | ||
| 2020-09-30 | 19.94M shares 10-Q · filed 2021-11-08 | 18.74M shares derived: average of 2 quarters · filed 2021-11-08 | 18.29M shares 10-Q · filed 2021-11-08 | 18.40M shares derived: average of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | 17.54M shares 10-Q · filed 2021-08-09 | 17.46M shares 10-Q · filed 2021-08-09 | 17.89M shares derived: average of 3 quarters · filed 2021-08-09 | 16.99M shares derived: average of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | 18.73M shares 10-Q · filed 2021-05-10 | 18.06M shares derived: average of 2 quarters · filed 2021-05-10 | 16.81M shares derived: average of 3 quarters · filed 2021-05-10 | 13.14M shares derived: average of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | 17.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 15.85M shares derived: average of 2 quarters · filed 2021-03-11 | 11.28M shares derived: average of 3 quarters · filed 2021-03-11 | 8.66M shares 10-K · filed 2021-03-11 | ||
| 2019-09-30 | 14.30M shares 10-Q · filed 2020-11-09 | 14.30M shares 10-Q · filed 2019-11-12 | 8.23M shares derived: average of 2 quarters · filed 2020-11-09 | 5.75M shares 10-Q · filed 2020-11-09 | 5.75M shares 10-Q · filed 2019-11-12 | 5.07M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 2.15M shares 10-Q · filed 2020-08-10 | 2.04M shares 10-Q · filed 2020-08-10 | 2.00M shares derived: average of 3 quarters · filed 2020-08-10 | 1.97M shares derived: average of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | 1.92M shares 10-Q · filed 2020-05-11 | 1.92M shares derived: average of 2 quarters · filed 2020-05-11 | 1.92M shares derived: average of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | 1.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 1.91M shares derived: average of 2 quarters · filed 2020-03-10 | 1.91M shares 10-K · filed 2020-03-10 | |||
| 2018-09-30 | 1.91M shares 10-Q · filed 2019-11-12 | 1.90M shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |